ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 226 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $326 | -41.5% | 7,060 | -49.2% | 0.04% | -19.6% |
| Q1 2023 | $557 | -99.9% | 13,890 | -33.7% | 0.05% | -40.7% |
| Q3 2022 | $868,000 | -10.9% | 20,950 | +105.0% | 0.09% | -12.2% |
| Q2 2021 | $974,000 | +286.5% | 10,220 | +462.5% | 0.10% | +139.0% |
| Q4 2020 | $252,000 | -59.2% | 1,817 | -79.6% | 0.04% | -59.4% |
| Q1 2019 | $617,000 | +174.2% | 8,900 | +93.2% | 0.10% | +65.6% |
| Q2 2016 | $225,000 | – | 4,606 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 75,000 | $5,084,000 | 2.52% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,237,825 | $83,900,000 | 1.18% |
| CAPITAL INTERNATIONAL LTD /CA/ | 206,718 | $14,011,000 | 0.91% |
| Cormorant Asset Management, LP | 75,000 | $5,084,000 | 0.74% |
| Capital International Sarl | 107,450 | $7,283,000 | 0.63% |
| Rock Springs Capital Management LP | 159,750 | $10,828,000 | 0.62% |
| Opus Point Partners Management, LLC | 12,201 | $827,000 | 0.61% |
| Hood River Capital Management LLC | 109,629 | $7,431,000 | 0.56% |
| Aureus Asset Management, LLC | 50,740 | $2,927,000 | 0.51% |
| ROCKEFELLER FINANCIAL SERVICES INC | 374,663 | $25,395,000 | 0.51% |